# Biomat USA, Inc. – FDA Inspection, Nov 1, 2010

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/07a5a0f7-3bbc-4200-ae55-42095ab47725
Source feed: FDA_Inspections

> FDA inspection 696650 of Biomat USA, Inc., November 01, 2010. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 696650
- Company Name: Biomat USA, Inc.
- Inspection Date: 2010-11-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1190568 - 2022-11-03
- FDA Inspection 1044832 - 2018-03-13
- FDA Inspection 893917 - 2014-09-05
- [FDA Inspection 759129 - 2011-12-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ae5f1402-481e-4900-95c6-c29a823a22c8)
- [FDA Inspection 554942 - 2008-12-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/300bb39e-8aa9-4da2-8929-040e178e60fc)

Company: https://www.keypedia.com/companies/biomat-usa-inc/37b43d20-857d-4a9f-b5f5-9070f50c179f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d